In plain language
A health plan company must cover amino acid-based elemental formula when it is medically necessary. The statute lists conditions for which the formula is medically necessary, including cystic fibrosis; amino acid, organic acid, and fatty acid metabolic and malabsorption disorders; IgE mediated food protein allergies; food protein-induced enterocolitis syndrome; eosinophilic esophagitis, gastroenteritis, and colitis; and mast cell activation syndrome. That list is examples, not a complete set.
Where this summary and the official text differ, the official text controls.
What this means for you
Health plans must cover amino acid-based elemental formula when a patient medically needs it. The statute names example qualifying conditions (such as cystic fibrosis, certain metabolic and malabsorption disorders, IgE mediated food allergies, eosinophilic GI conditions, and mast cell activation syndrome) but says coverage is not limited to those listed.Text of the law
Subdivision 1. Definition.
(a) For purposes of this section, the following term has the meaning given.
(b) “Formula” means an amino acid-based elemental formula.
Subd. 2. Required coverage.
A health plan company must provide coverage for formula when formula is medically necessary.
Subd. 3. Covered conditions.
Conditions for which formula is medically necessary include but are not limited to:
(1) cystic fibrosis;
(2) amino acid, organic acid, and fatty acid metabolic and malabsorption disorders;
(3) IgE mediated allergies to food proteins;
(4) food protein-induced enterocolitis syndrome;
(5) eosinophilic esophagitis;
(6) eosinophilic gastroenteritis;
(7) eosinophilic colitis; and
(8) mast cell activation syndrome.
History: 2024 c 127 art 57 s 40
2024 c 127 art 57 s 40